Atlas Trials

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

Clinical trial NCT02234934 · COMPLETED

Trial details

NCT number
NCT02234934
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Granulomatous Disease, Chronic, X-linked
Start date
2015-10-29
Primary completion
2024-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.